vs
Side-by-side financial comparison of Cytek Biosciences, Inc. (CTKB) and OLAPLEX HOLDINGS, INC. (OLPX). Click either name above to swap in a different company.
OLAPLEX HOLDINGS, INC. is the larger business by last-quarter revenue ($105.1M vs $62.1M, roughly 1.7× Cytek Biosciences, Inc.). OLAPLEX HOLDINGS, INC. runs the higher net margin — -12.5% vs -70.9%, a 58.5% gap on every dollar of revenue. On growth, Cytek Biosciences, Inc. posted the faster year-over-year revenue change (8.1% vs 4.3%). OLAPLEX HOLDINGS, INC. produced more free cash flow last quarter ($32.6M vs $-1.8M). Over the past eight quarters, Cytek Biosciences, Inc.'s revenue compounded faster (17.7% CAGR vs 3.1%).
Cytek Biosciences, Inc. develops, manufactures and sells high-performance flow cytometry systems, associated reagents and analysis software. Its solutions serve life science research, clinical diagnostics and biopharmaceutical sectors, with a global customer base across North America, Europe and the Asia-Pacific region.
Olaplex Holdings, Inc. is a specialty beauty company developing and selling patented bond-repair hair care products. It runs three core segments: professional salon distribution, direct-to-consumer sales, and third-party retail, serving customers across North America, Europe, and Asia-Pacific with products that repair and protect damaged hair.
CTKB vs OLPX — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $62.1M | $105.1M |
| Net Profit | $-44.1M | $-13.1M |
| Gross Margin | 52.9% | 68.0% |
| Operating Margin | -9.0% | -4.3% |
| Net Margin | -70.9% | -12.5% |
| Revenue YoY | 8.1% | 4.3% |
| Net Profit YoY | -557.1% | -48.9% |
| EPS (diluted) | — | $-0.02 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $62.1M | $105.1M | ||
| Q3 25 | $52.3M | $114.6M | ||
| Q2 25 | $45.6M | $106.3M | ||
| Q1 25 | $41.5M | $97.0M | ||
| Q4 24 | $57.5M | $100.7M | ||
| Q3 24 | $51.5M | $119.1M | ||
| Q2 24 | $46.6M | $103.9M | ||
| Q1 24 | $44.9M | $98.9M |
| Q4 25 | $-44.1M | $-13.1M | ||
| Q3 25 | $-5.5M | $11.1M | ||
| Q2 25 | $-5.6M | $-7.7M | ||
| Q1 25 | $-11.4M | $465.0K | ||
| Q4 24 | $9.6M | $-8.8M | ||
| Q3 24 | $941.0K | $14.8M | ||
| Q2 24 | $-10.4M | $5.8M | ||
| Q1 24 | $-6.2M | $7.7M |
| Q4 25 | 52.9% | 68.0% | ||
| Q3 25 | 52.7% | 69.1% | ||
| Q2 25 | 52.3% | 71.2% | ||
| Q1 25 | 48.6% | 69.5% | ||
| Q4 24 | 58.5% | 66.3% | ||
| Q3 24 | 56.3% | 68.6% | ||
| Q2 24 | 54.6% | 69.7% | ||
| Q1 24 | 51.3% | 72.1% |
| Q4 25 | -9.0% | -4.3% | ||
| Q3 25 | -17.6% | 3.7% | ||
| Q2 25 | -23.3% | -1.1% | ||
| Q1 25 | -36.1% | 8.7% | ||
| Q4 24 | 5.2% | 3.0% | ||
| Q3 24 | -8.2% | 23.5% | ||
| Q2 24 | -18.3% | 15.7% | ||
| Q1 24 | -23.9% | 19.8% |
| Q4 25 | -70.9% | -12.5% | ||
| Q3 25 | -10.5% | 9.7% | ||
| Q2 25 | -12.2% | -7.3% | ||
| Q1 25 | -27.5% | 0.5% | ||
| Q4 24 | 16.8% | -8.7% | ||
| Q3 24 | 1.8% | 12.4% | ||
| Q2 24 | -22.4% | 5.6% | ||
| Q1 24 | -13.8% | 7.8% |
| Q4 25 | — | $-0.02 | ||
| Q3 25 | — | $0.02 | ||
| Q2 25 | — | $-0.01 | ||
| Q1 25 | — | $0.00 | ||
| Q4 24 | — | $-0.01 | ||
| Q3 24 | — | $0.02 | ||
| Q2 24 | — | $0.01 | ||
| Q1 24 | — | $0.01 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $90.9M | $318.7M |
| Total DebtLower is stronger | — | $352.3M |
| Stockholders' EquityBook value | $341.7M | $879.4M |
| Total Assets | $461.5M | $1.5B |
| Debt / EquityLower = less leverage | — | 0.40× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $90.9M | $318.7M | ||
| Q3 25 | $93.3M | $286.4M | ||
| Q2 25 | $75.5M | $289.3M | ||
| Q1 25 | $95.3M | $580.9M | ||
| Q4 24 | $98.7M | $586.0M | ||
| Q3 24 | $162.3M | $538.8M | ||
| Q2 24 | $177.9M | $507.9M | ||
| Q1 24 | $168.8M | $507.5M |
| Q4 25 | — | $352.3M | ||
| Q3 25 | — | $352.1M | ||
| Q2 25 | — | $351.9M | ||
| Q1 25 | — | $649.1M | ||
| Q4 24 | — | $650.5M | ||
| Q3 24 | — | $651.8M | ||
| Q2 24 | — | $653.1M | ||
| Q1 24 | — | $654.4M |
| Q4 25 | $341.7M | $879.4M | ||
| Q3 25 | $378.6M | $888.7M | ||
| Q2 25 | $377.6M | $874.2M | ||
| Q1 25 | $379.6M | $878.3M | ||
| Q4 24 | $395.7M | $874.4M | ||
| Q3 24 | $385.5M | $879.7M | ||
| Q2 24 | $389.1M | $863.3M | ||
| Q1 24 | $392.6M | $855.7M |
| Q4 25 | $461.5M | $1.5B | ||
| Q3 25 | $494.9M | $1.5B | ||
| Q2 25 | $493.3M | $1.5B | ||
| Q1 25 | $482.6M | $1.8B | ||
| Q4 24 | $499.5M | $1.8B | ||
| Q3 24 | $491.2M | $1.8B | ||
| Q2 24 | $483.7M | $1.8B | ||
| Q1 24 | $492.1M | $1.8B |
| Q4 25 | — | 0.40× | ||
| Q3 25 | — | 0.40× | ||
| Q2 25 | — | 0.40× | ||
| Q1 25 | — | 0.74× | ||
| Q4 24 | — | 0.74× | ||
| Q3 24 | — | 0.74× | ||
| Q2 24 | — | 0.76× | ||
| Q1 24 | — | 0.76× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-771.0K | $32.7M |
| Free Cash FlowOCF − Capex | $-1.8M | $32.6M |
| FCF MarginFCF / Revenue | -2.9% | 31.0% |
| Capex IntensityCapex / Revenue | 1.6% | 0.1% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-8.8M | $58.3M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-771.0K | $32.7M | ||
| Q3 25 | $-3.9M | $8.0M | ||
| Q2 25 | $108.0K | $20.9M | ||
| Q1 25 | $-125.0K | $-2.9M | ||
| Q4 24 | $2.0M | $49.7M | ||
| Q3 24 | $13.2M | $33.5M | ||
| Q2 24 | $6.2M | $16.2M | ||
| Q1 24 | $4.0M | $43.7M |
| Q4 25 | $-1.8M | $32.6M | ||
| Q3 25 | $-4.6M | $7.9M | ||
| Q2 25 | $-1.5M | $20.8M | ||
| Q1 25 | $-974.0K | $-3.0M | ||
| Q4 24 | $1.1M | $49.2M | ||
| Q3 24 | $12.2M | $33.3M | ||
| Q2 24 | $5.2M | $16.1M | ||
| Q1 24 | $3.4M | $43.3M |
| Q4 25 | -2.9% | 31.0% | ||
| Q3 25 | -8.7% | 6.9% | ||
| Q2 25 | -3.2% | 19.6% | ||
| Q1 25 | -2.3% | -3.1% | ||
| Q4 24 | 1.9% | 48.9% | ||
| Q3 24 | 23.7% | 28.0% | ||
| Q2 24 | 11.0% | 15.5% | ||
| Q1 24 | 7.6% | 43.7% |
| Q4 25 | 1.6% | 0.1% | ||
| Q3 25 | 1.3% | 0.1% | ||
| Q2 25 | 3.5% | 0.1% | ||
| Q1 25 | 2.0% | 0.0% | ||
| Q4 24 | 1.6% | 0.4% | ||
| Q3 24 | 2.0% | 0.1% | ||
| Q2 24 | 2.3% | 0.1% | ||
| Q1 24 | 1.3% | 0.5% |
| Q4 25 | — | — | ||
| Q3 25 | — | 0.72× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | -6.27× | ||
| Q4 24 | 0.21× | — | ||
| Q3 24 | 14.05× | 2.26× | ||
| Q2 24 | — | 2.81× | ||
| Q1 24 | — | 5.64× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CTKB
| Products | $46.6M | 75% |
| Services | $15.5M | 25% |
OLPX
| Sales Channel Directly To Consumer | $43.6M | 42% |
| Sales Channel Through Intermediary Professional | $36.8M | 35% |
| Sales Channel Through Intermediary Specialty Retail | $24.7M | 23% |
